It was a good week for stocks and the S&P 500 is now in positive territory YTD, but I wouldn’t be making any big bets that it ...

Discover why Genmab's antibody platforms, growing royalties, and late-stage pipeline make it a top biotech stock for ...

"For too long, Johnson & Johnson has used tying arrangements and other tactics to interfere with fair competition from lower cost, FDA regulated, reprocessed ‘single-use’ devi ...

What may have seemed like a tedious task quickly turned into a lottery victory for one Illinois man. The lucky player, who ...

Bea Priestley, formally known as Blair Davenport, speaks about the support she received following her release from WWE.

Dividend stocks are a foundational building block for creating a retirement portfolio, offering a reliable income stream and ...

Johnson & Johnson, with the endorsement of the Emirates Gastroenterology & Hepatology Society, has created the largest ...

Intravascular lithotripsy (IVL) has become synonymous with billion-dollar deals and calcified lesion vessel treatment. Yet distinguishing its true clinical promise from the financial buzz is no easy ...

Stonebrook Private Inc. slightly reduced its position in Johnson & Johnson, selling 2,057 shares, yet still holds $3.24 ...

Uncertainty continues to grip markets as the Donald Trump administration signals a potential return to aggressive trade ...